News

The FDA's breakthrough devices program helps the industry with faster review times, but the benefit to patients is unclear.
As devices come onto the market that have to follow the new FDA guidance of SBOMs and patching, backdoors may become easier ...
Polymed has set an ambitious target to grow its US revenue to ;$20-25 million opportunity' within the next three to four ...
Generative AI chatbot for doctors called 'Prof. Valmed' earns E.U. approval. In the U.S., FDA is yet to issue guidelines on ...